MYX 4.50% $4.03 mayne pharma group limited

  1. 33 Posts.
    Presentation page 20 shows a negative revenue for dermatology products of $21.9m in 4 months with no explanation to whether this is once off or continuing problem. This is buried on page 20 and shoudl have been strongly addressed.
    I see the Finance Facility is completely retired.
    They are budgeting on monthly script issue to rise from150k to 350k.- this feels very optimistic.

 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.